PRECIPIO DIAGNOSTICS
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.
PRECIPIO DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2011-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.precipiodx.com
Total Employee:
11+
Status:
Active
Contact:
(203)787-7888
Total Funding:
3.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Current Advisors List
Board_member
Current Employees Featured
Ilan Danieli CEO @ Precipio Diagnostics
CEO
2011-01-01
A. Zaki Sabet Co-Founder and COO @ Precipio Diagnostics
Co-Founder and COO
2017-06-01
Jeffrey Sklar Chief Scientific Officer @ Precipio Diagnostics
Chief Scientific Officer
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-06-30 | Transgenomic | Transgenomic acquired by Precipio Diagnostics | N/A |
Investors List
Eli Whitney Fund
Eli Whitney Fund investment in Series B - Precipio Diagnostics
Kuzari Group
Kuzari Group investment in Series B - Precipio Diagnostics
Ironwood Capital
Ironwood Capital investment in Series B - Precipio Diagnostics
Enhanced Capital Partners
Enhanced Capital Partners investment in Series B - Precipio Diagnostics
Advantage Capital
Advantage Capital investment in Series B - Precipio Diagnostics
Connecticut Innovations
Connecticut Innovations investment in Series B - Precipio Diagnostics
Official Site Inspections
http://www.precipiodx.com Semrush global rank: 4.99 M Semrush visits lastest month: 1.69 K
- Host name: 172.66.40.172
- IP address: 172.66.40.172
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
